KK
SANA icon

KLP Kapitalforvaltning’s Sana Biotechnology SANA Stock Holding History

KLP Kapitalforvaltning’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$104K Hold
36,200
– – ﹤0.01% 2043
2025
Q4 		$147K Buy
36,200
+8,000
+28% +$35.8K ﹤0.01% 1948
2025
Q3 		$100K Buy
+28,200
New +$102K ﹤0.01% 2065
2025
Q2 		– Sell
-24,200
Closed -$40.7K – 2256
2025
Q1 		$40.7K Hold
24,200
– – ﹤0.01% 2211
2024
Q4 		$39.4K Buy
+24,200
New +$72.2K ﹤0.01% 2262

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return

KLP Kapitalforvaltning's SANA Position: Q1 2026 in Review

KLP Kapitalforvaltning held its Sana Biotechnology (SANA) position steady in Q1 2026 at 36,200 shares worth $104K. The position accounts for ﹤0.01% of the portfolio, ranked #2043.

KLP Kapitalforvaltning first reported a position in SANA in Q4 2024 and has held it in 5 quarters since. The position peaked at $147K in Q4 2025. 202 funds tracked by Wall St. Rank hold SANA as of Q1 2026.

  • KLP Kapitalforvaltning held 36,200 shares of Sana Biotechnology worth $104K as of Q1 2026.
  • KLP Kapitalforvaltning left its Sana Biotechnology share count unchanged in Q1 2026.
  • Sana Biotechnology made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q1 2026, its #2043 holding.
  • KLP Kapitalforvaltning first reported a position in Sana Biotechnology in Q4 2024 and has held it in 5 quarters since.
  • KLP Kapitalforvaltning's Sana Biotechnology position peaked at $147K in Q4 2025.
  • 202 funds tracked by Wall St. Rank held Sana Biotechnology as of Q1 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q1 2026, filed 29 Apr 2026.